Institutional & Family Asset Management’s Anika Therapeutics ANIK Stock Holding History

Institutional & Family Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-108	Closed	-$5K	–	928
2020 Q4	$5K	Hold	108	–	–	﹤0.01%	632
2020 Q3	$4K	Hold	108	–	–	﹤0.01%	605
2020 Q2	$4K	Sell	108 -37	-26%	-$1.22K	﹤0.01%	596
2020 Q1	$4K	Hold	145	–	–	﹤0.01%	551
2019 Q4	$8K	Hold	145	–	–	﹤0.01%	530
2019 Q3	$8K	Sell	145 -17	-10%	-$873	﹤0.01%	498
2019 Q2	$7K	Hold	162	–	–	﹤0.01%	541
2019 Q1	$5K	Hold	162	–	–	﹤0.01%	592
2018 Q4	$5K	Hold	162	–	–	﹤0.01%	579
2018 Q3	$7K	Hold	162	–	–	﹤0.01%	570
2018 Q2	$5K	Hold	162	–	–	﹤0.01%	602
2018 Q1	$8K	Buy	+162	New	+$9.15K	﹤0.01%	534

Other funds holding ANIK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Institutional & Family Asset Management's ANIK Position: Q1 2021 in Review

Institutional & Family Asset Management sold out of Anika Therapeutics (ANIK) in Q1 2021, closing a stake of 108 shares — an estimated $5K sold.

Institutional & Family Asset Management first reported a position in ANIK in Q1 2018 and held it in 12 quarters. The position peaked at $8K in Q4 2019. 146 funds tracked by Wall St. Rank hold ANIK as of Q1 2021.

Institutional & Family Asset Management reported no remaining Anika Therapeutics position as of Q1 2021 after selling out during the quarter.
Institutional & Family Asset Management sold 108 Anika Therapeutics shares in Q1 2021, an estimated $5K.
Institutional & Family Asset Management first reported a position in Anika Therapeutics in Q1 2018 and held it in 12 quarters.
Institutional & Family Asset Management's Anika Therapeutics position peaked at $8K in Q4 2019.
146 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2021.

Based on Institutional & Family Asset Management's 13F filing for Q1 2021, filed 6 May 2021.